胍丁胺
情绪障碍
医学
神经科学
上瘾
药理学
生物信息学
精神科
精氨酸
心理学
生物
生物化学
氨基酸
焦虑
作者
John E. Piletz,Feyza Arıcıoğlu,Juei‐Tang Cheng,Carolyn A. Fairbanks,Varda H. Gilad,Britta Haenisch,Angelos E Halaris,Samin Hong,Jong Eun Lee,Jin Li,Ping Liu,Gerhard Josef Molderings,Ana Lúcia S. Rodrigues,Joseph A. Satriano,Gong Je Seong,George L. Wilcox,Ning Wu,Gad M. Gilad
标识
DOI:10.1016/j.drudis.2013.05.017
摘要
Agmatine (decarboxylated arginine) has been known as a natural product for over 100 years, but its biosynthesis in humans was left unexplored owing to long-standing controversy. Only recently has the demonstration of agmatine biosynthesis in mammals revived research, indicating its exceptional modulatory action at multiple molecular targets, including neurotransmitter systems, nitric oxide (NO) synthesis and polyamine metabolism, thus providing bases for broad therapeutic applications. This timely review, a concerted effort by 16 independent research groups, draws attention to the substantial preclinical and initial clinical evidence, and highlights challenges and opportunities, for the use of agmatine in treating a spectrum of complex diseases with unmet therapeutic needs, including diabetes mellitus, neurotrauma and neurodegenerative diseases, opioid addiction, mood disorders, cognitive disorders and cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI